Ascendis Pharma - Articles and news items

Positive top-line results for Ascendis Pharma’s TransCon Growth Hormone

Industry news / 30 July 2015 / Victoria White

Ascendis Pharma has announced positive top-line results from a study evaluating the safety and efficacy of TransCon Growth Hormone in children with GHD…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+